These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 2785514
41. A new method for labeling microspheres with 68Ga. Hayes RL, Carlton JE, Kuniyasu Y. Eur J Nucl Med; 1981; 6(11):531-3. PubMed ID: 7327191 [Abstract] [Full Text] [Related]
42. Comparison of estimated human dose of (68)Ga-MAA with (99m)Tc-MAA based on rat data. Shanehsazzadeh S, Lahooti A, Yousefnia H, Geramifar P, Jalilian AR. Ann Nucl Med; 2015 Oct; 29(8):745-53. PubMed ID: 26139003 [Abstract] [Full Text] [Related]
43. Gallium-68 perfusion positron emission tomography/computed tomography to assess pulmonary function in lung cancer patients undergoing surgery. Le Roux PY, Leong TL, Barnett SA, Hicks RJ, Callahan J, Eu P, Manser R, Hofman MS. Cancer Imaging; 2016 Aug 20; 16(1):24. PubMed ID: 27544383 [Abstract] [Full Text] [Related]
44. Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET. Herrero P, Hartman JJ, Green MA, Anderson CJ, Welch MJ, Markham J, Bergmann SR. J Nucl Med; 1996 Aug 20; 37(8):1294-300. PubMed ID: 8708759 [Abstract] [Full Text] [Related]
45. A gallium-68 radiopharmaceutical that is retained in myocardium: 68Ga[(4,6-MeO2sal)2BAPEN]+. Tsang BW, Mathias CJ, Green MA. J Nucl Med; 1993 Jul 20; 34(7):1127-31. PubMed ID: 8315489 [Abstract] [Full Text] [Related]
46. Preparation of ⁶⁸Ga-labelled DOTA-peptides using a manual labelling approach for small-animal PET imaging. Romero E, Martínez A, Oteo M, García A, Morcillo MA. Appl Radiat Isot; 2016 Jan 20; 107():113-120. PubMed ID: 26492321 [Abstract] [Full Text] [Related]
48. Preclinical characterization of 18F-MAA, a novel PET surrogate of 99mTc-MAA. Wu SY, Kuo JW, Chang TK, Liu RS, Lee RC, Wang SJ, Lin WJ, Wang HE. Nucl Med Biol; 2012 Oct 20; 39(7):1026-33. PubMed ID: 22762865 [Abstract] [Full Text] [Related]
49. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors. Gaertner FC, Beer AJ, Souvatzoglou M, Eiber M, Fürst S, Ziegler SI, Brohl F, Schwaiger M, Scheidhauer K. Invest Radiol; 2013 May 20; 48(5):263-72. PubMed ID: 23385399 [Abstract] [Full Text] [Related]
50. A methodical 68Ga-labelling study of DO2A-(butyl-L-tyrosine)2 with cation-exchanger post-processed 68Ga: practical aspects of radiolabelling. Riss PJ, Burchardt C, Roesch F. Contrast Media Mol Imaging; 2011 May 20; 6(6):492-8. PubMed ID: 22144027 [Abstract] [Full Text] [Related]
51. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. Henze M, Schuhmacher J, Hipp P, Kowalski J, Becker DW, Doll J, Mäcke HR, Hofmann M, Debus J, Haberkorn U. J Nucl Med; 2001 Jul 20; 42(7):1053-6. PubMed ID: 11438627 [Abstract] [Full Text] [Related]
52. Stable labelling of serum albumin microspheres with gallium-68. Maziere B, Loc'h C, Steinling M, Comar D. Int J Rad Appl Instrum A; 1986 Jul 20; 37(4):360-1. PubMed ID: 3021659 [Abstract] [Full Text] [Related]
53. Validation of (68)Ge/(68)Ga generator processing by chemical purification for routine clinical application of (68)Ga-DOTATOC. Asti M, De Pietri G, Fraternali A, Grassi E, Sghedoni R, Fioroni F, Roesch F, Versari A, Salvo D. Nucl Med Biol; 2008 Aug 20; 35(6):721-4. PubMed ID: 18678358 [Abstract] [Full Text] [Related]
54. In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. Mathias CJ, Welch MJ, Green MA, Diril H, Meares CF, Gropler RJ, Bergmann SR. J Nucl Med; 1991 Mar 20; 32(3):475-80. PubMed ID: 2005455 [Abstract] [Full Text] [Related]
55. 68Ga-labeled oligonucleotides for in vivo imaging with PET. Roivainen A, Tolvanen T, Salomäki S, Lendvai G, Velikyan I, Numminen P, Välilä M, Sipilä H, Bergström M, Härkönen P, Lönnberg H, Långström B. J Nucl Med; 2004 Feb 20; 45(2):347-55. PubMed ID: 14960659 [Abstract] [Full Text] [Related]
56. Imaging Characteristics and First Experience of [68Ga]THP-PSMA, a Novel Probe for Rapid Kit-Based Ga-68 Labeling and PET Imaging: Comparative Analysis with [68Ga]PSMA I&T. Derlin T, Schmuck S, Juhl C, Teichert S, Zörgiebel J, Wester HJ, Schneefeld SM, Walte ACA, Thackeray JT, Ross TL, Bengel FM. Mol Imaging Biol; 2018 Aug 20; 20(4):650-658. PubMed ID: 29344901 [Abstract] [Full Text] [Related]
58. Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning. Siva S, Devereux T, Ball DL, MacManus MP, Hardcastle N, Kron T, Bressel M, Foroudi F, Plumridge N, Steinfort D, Shaw M, Callahan J, Hicks RJ, Hofman MS. Technol Cancer Res Treat; 2016 Feb 20; 15(1):114-21. PubMed ID: 25575575 [Abstract] [Full Text] [Related]
59. Preparation and imaging of rhenium-188 labeled human serum albumin microsphere in orthotopic hepatoma rats. Ni HC, Yu CY, Chen SJ, Chen LC, Lin CH, Lee WC, Chuang CH, Ho CL, Chang CH, Lee TW. Appl Radiat Isot; 2015 May 20; 99():117-21. PubMed ID: 25748057 [Abstract] [Full Text] [Related]
60. Preclinical Evaluation of 68Ga-MAA from Commercial Available 99mTc-MAA Kit. Shanehsazzadeh S, Jalilian AR, Lahooti A, Geramifar P, Beiki D, Yousefnia H, Rabiee A, Mazidi M, Mirshojaei SF, Maus S. Iran J Pharm Res; 2017 May 20; 16(4):1415-1423. PubMed ID: 29552050 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]